ABCL: שווי שוק לרווח נקי מותאם קצב צמיחה AbCellera Biologics Inc.

The PEG ratio demonstrates a struggle between buyers and sellers, with 0.00 representing a fresh level. AbCellera Biologics (ABCL) price action remains independent of macroeconomics, as profits are based on royalties and research milestones. AbCellera Biologics (ABCL) utilizes AI for accelerated antibody discovery within the B2B sector. Stability is ensured by the international diversification of biocomponent supplies for laboratories.
פילוחי מדדים ואנליטיקה של חברת AbCellera (ABCL)

Reductions in partner R&D budgets are putting pressure on AbCellera Biologics (ABCL) revenue, although a significant liquidity reserve stabilizes operational resilience. The peg_co multiple compares the current P/E to earnings growth rates to identify asset undervaluation; a drop in this indicator below one signals high investment attractiveness for the company relative to its expansion dynamics and market capitalization.